Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting the injection technique right matters as much as the medicine itself. Weight loss injections — Mounjaro (tirzepatide) and Wegovy (semaglutide) — are administered once a week under the skin, using a pre-filled pen that guides you through every step. These are prescription-only medicines; a clinical assessment confirms whether they are suitable for you before any treatment begins. Once approved, the practical side is straightforward, and most people feel confident by their second or third dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A quick pre-injection habit takes under a minute and prevents most avoidable problems. Hold the pen up to the light and look through the viewing window: the liquid should be clear or very slightly yellow, with no particles or cloudiness. Check the expiry date printed on the label. If either of these is off, do not use that pen, contact your prescriber or pharmacy. Then confirm you are using the correct dose pen; Mounjaro, for example, comes in six strengths (2.5 mg through to 15 mg), and the strength printed on the cartridge should match what your prescriber has prescribed for this stage of your treatment.
Let the pen sit at room temperature for around 30 minutes before injecting if it has come straight from the fridge. Cold liquid can sting more on the way in, and waiting briefly makes the process more comfortable without affecting how the medicine works. Wash your hands thoroughly while you wait. That is the whole pre-check: examine, confirm, warm, wash.
For guidance on how often these injections are given across a treatment course, the injection frequency page covers the full titration schedule and what to expect between doses.
The three approved injection sites are the abdomen, the outer thigh, and the outer upper arm. The abdomen is the most commonly chosen: aim for the soft fatty tissue between the lower ribs and the hip bone, staying at least a hand's width away from the navel. The outer thigh works well for people who find the abdomen uncomfortable. The upper arm is an option but can be harder to self-administer without some practice.
Rotation matters. Using exactly the same spot every week can cause lipohypertrophy, a build-up of fatty tissue beneath the skin that changes how medicine is absorbed. A simple system is to mentally divide each site into sections and move around them in turn. You can also switch between sites entirely: abdomen one week, thigh the next. The NHS tirzepatide patient information page notes that rotating injection sites is part of the standard technique for subcutaneous injections like these.
Avoid skin that is bruised, tender, or showing any redness. Never inject through clothing. If you are curious about the broader landscape of licensed weight loss injections available in the UK, there is a full overview that compares the options and how they work.
Once you have chosen your site, clean the area with an alcohol swab and let it dry fully, injecting through wet skin can sting. Remove the pen cap. Place the pen flat against the skin (no need to pinch it up; Mounjaro's KwikPen and the Wegovy pen are both designed to be pressed straight against the skin surface). Press the pen firmly and activate the injection button as described in your leaflet. Hold the pen in place until the injection is complete, the viewing window or plunger will confirm this. Then lift the pen straight away from the skin.
Do not rub the site afterwards; it does not help the medicine absorb and can cause irritation. A small amount of redness or a tiny bump at the site is normal and usually settles within a few hours. If you notice prolonged pain, swelling, or any signs of infection, contact a clinician.
After injecting, attach the outer cap back onto the needle before removing it from the pen. Used needles should go straight into a sealed sharps container, never loose in household waste or recycling. Your local pharmacy or GP surgery can advise on sharps collection in your area. The full guide to using weight loss injections covers disposal and post-injection care in more detail.
Some people notice injection-site reactions: redness, itching, mild bruising, or a small lump under the skin. These are generally short-lived and become less frequent as you settle into a routine and rotate sites consistently. Keeping needles fresh for every dose makes a real difference here, a blunted needle drags slightly through skin and causes more local irritation than a sharp one. If you want to understand more about how weight loss injections work and what to expect from treatment, that page brings together the key information in one place. Changing the needle between each injection is straightforward; compatible needles for these pens are available if you need to restock.
The more commonly reported side effects of GLP-1 and dual-agonist medicines are gastrointestinal rather than injection-related: nausea, loose stools, constipation, and reflux are most typical, particularly after starting treatment or moving up a dose. These usually ease within a week or two as your body adjusts. If you would like a clear walkthrough of how to take the weight loss injection correctly, including tips for managing these early effects alongside technique, that guide is a useful companion to this page.
In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines. Severe, persistent stomach pain that spreads to the back (with or without vomiting) warrants urgent medical attention. Report any suspected side effects through the MHRA Yellow Card scheme, which also allows you to flag any concerns about the medicine or its source. If you have questions about which injection might suit your circumstances, speaking to our prescribers is the clearest next step, and our step-by-step guide to injecting weight loss medication is a helpful resource to revisit whenever you want a confidence check on your technique.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.